Open-Label Extension of Ponsegromab Shows Efficacy in Cancer-Associated Cachexia
Kisqali Plus Aromatase Inhibitor Shows Long-Term Benefit in Early Breast Cancer
Imfinzi Plus Chemo Improves Survival in G/GEJ Adenocarcinoma
Imfinzi Plus BCG Improves Disease-Free Survival in High-Risk NMIBC